Last reviewed · How we verify
KNP2002
At a glance
| Generic name | KNP2002 |
|---|---|
| Also known as | KV-0132 |
| Sponsor | KinoPharma Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- OM202JP Clinical Study of KNP2002 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KNP2002 CI brief — competitive landscape report
- KNP2002 updates RSS · CI watch RSS
- KinoPharma Inc. portfolio CI